Literature DB >> 9585724

Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs.

K L Wisner1, J M Perel, J Blumer.   

Abstract

OBJECTIVE: The authors' goal was to study the serum sertraline levels of breast-feeding mothers and their infants.
METHOD: They obtained serum levels of sertraline and N-desmethylsertraline in nine mother-infant pairs.
RESULTS: Sertraline levels were very low (less than 2 ng/ml) in seven of the nine infants and low (3 ng/ml) in one. N-Desmethylsertraline levels were also low (6 ng/ml or less) in seven of the nine infants. One infant had a high level of N-desmethylsertraline, and one infant had unusual serum sertraline and N-desmethylsertraline values (half of its mother's levels). All infants were thriving.
CONCLUSIONS: Most breast-feeding infants whose mothers were taking sertraline had very low serum levels of both sertraline and N-desmethylsertraline, consistent with published reports. The authors discuss in detail the one infant with unusually high levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585724     DOI: 10.1176/ajp.155.5.690

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

1.  Excretion of fluvoxamine into breast milk.

Authors:  S Hägg; K Granberg; L Carleborg
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

Review 2.  Antidepressants and breast-feeding: a review of the literature.

Authors:  S Dodd; A Buist; T R Norman
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 3.  Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 4.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

Review 5.  Sertraline and breastfeeding: review and meta-analysis.

Authors:  Emily Pinheiro; Debra L Bogen; Denada Hoxha; Jody D Ciolino; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2015-01-15       Impact factor: 3.633

Review 6.  Benefits and risks to mother and infant of drug treatment for postnatal depression.

Authors:  Shaila Misri; Xanthoula Kostaras
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 7.  Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles.

Authors:  Hannah K Betcher; Katherine L Wisner
Journal:  J Womens Health (Larchmt)       Date:  2019-12-03       Impact factor: 2.681

Review 8.  Clinical pharmacokinetics of sertraline.

Authors:  C Lindsay DeVane; Heidi L Liston; John S Markowitz
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Are SSRIs safe for pregnant and breastfeeding women?

Authors:  S Misri; A Burgmann; D Kostaras
Journal:  Can Fam Physician       Date:  2000-03       Impact factor: 3.275

Review 10.  Use of psychotropic medications in treating mood disorders during lactation : practical recommendations.

Authors:  Malin Eberhard-Gran; Anne Eskild; Stein Opjordsmoen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.